Who is sponsoring NCT01952405?

NCT01952405 is sponsored by Mackay Memorial Hospital.

What drugs are being tested in NCT01952405?

Interventions in NCT01952405: Dialectical behavior therapy (DBT).

What condition does NCT01952405 study?

NCT01952405 studies Borderline Personality Disorder.

Is NCT01952405 still recruiting?

NCT01952405 is currently completed. Last updated 6 March 2017.

Last reviewed 2017-03-06 · How we verify

NCT01952405

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Efficacy of Dialectical Behavior Therapy in Patients With Borderline Personality Disorder

Completed NA Last updated 6 March 2017

What this trial tests

NA trial testing Dialectical behavior therapy (DBT) in Borderline Personality Disorder in 60 participants. Completed in 24 February 2017.

Timeline

18 May 2013

Primary endpoint
24 February 2017

24 February 2017

Quick facts

Lead sponsor	Mackay Memorial Hospital
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	single
Primary purpose	treatment
Enrollment	60
Start date	18 May 2013
Primary completion	24 February 2017
Estimated completion	24 February 2017
Sites	1 location across Taiwan

Drugs / interventions tested

Dialectical behavior therapy (DBT)

Conditions studied

Borderline Personality Disorder — all drugs for Borderline Personality Disorder →

Sponsor

Mackay Memorial Hospital

Who can join

Adults 18 to 60, any sex, with Borderline Personality Disorder. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of this study is to test the hypothesis: Primary hypothesis: Participants in the dialectical behavior therapy group have greater reductions in the frequency and severity of suicidal and non-suicidal self-injurious behaviors compared to participants in the alternative treatment group. Secondary Hypotheses: Participants in dialectical behavior therapy group have improved treatment outcomes compared to participants in alternative treatment, including mental health service utilization, symptoms of borderline personality and depression symptoms, suicidal thought and hopelessness, disability, and quality of life.

Publications & conference data

3 peer-reviewed publications reference this trial (live from Europe PMC):

Psychosocial interventions for self-harm in adults.
Hawton K, Witt KG, Taylor Salisbury TL, Arensman E, et al · · 2016 · cited 109× · PMID 27168519 · DOI 10.1002/14651858.cd012189
Psychosocial interventions for self-harm in adults.
Witt KG, Hetrick SE, Rajaram G, Hazell P, et al · · 2021 · cited 79× · PMID 33884617 · DOI 10.1002/14651858.cd013668.pub2
Dialectical Behavior Therapy in suicidal patients with borderline personality disorder: A pilot randomized controlled trial in Taiwan
Wu S, Huang H, Chen JS, Korslund K, et al · · 2023 · DOI 10.21203/rs.3.rs-2525027/v1

Verify or expand the search:

Other recruiting trials for Borderline Personality Disorder

Currently open trials in the same condition.

NCT06458933 — Testing Interventions for Borderline Personality Disorder. · Phase 2 · recruiting
NCT07001475 — A Study to Test How BI 3031185 is Tolerated by People With Borderline Personality Disorder or Attention-deficit/Hyperact · Phase 1 · recruiting
NCT07119541 — Testing an Alliance-Focused Dialectical Behaviour Therapy Training for Borderline Personality Disorder · NA · active not recruiting
NCT06446765 — Mindfulness-based Neurofeedback to Augment Psychotherapy for Adults With Borderline Personality Disorder · Phase 2 · recruiting
NCT07197502 — Treatment of Borderline Personality Disorder With rTMS · NA · recruiting

Other Mackay Memorial Hospital trials

Trials by the same sponsor.

NCT07370285 — AI-Supported Empathy Mapping to Enhance Communication and Grit in Pediatric Nursing Students · NA · not yet recruiting
NCT07537816 — Effects of Vadadustat on Anemia, Quality of Life, and Inflammation in Dialysis Patients · Phase 4 · not yet recruiting
NCT07479654 — AI-Enabled Frailty Risk Prediction in Adult Congenital Heart Disease · NA · not yet recruiting
NCT05483634 — Compare Vaginal Estrogen and Platelet-rich Plasma Over Women With Genitourinary Syndrome of Menopause · not yet recruiting
NCT07118267 — The Intervention of Lactobacillus Plantarum Probiotics in Adult Autistic Spectrum Disorders · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT01952405 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Mackay Memorial Hospital
Last refreshed: 6 March 2017

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT01952405.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing